Sign up for the Powder & Bulk Solids Weekly newsletter.
John S. Forrester
May 11, 2021
1 Min Read
Image courtesy of Nestle
Medical nutrition and consumer health firm Nestle Health Science has struck a deal to purchase Nuun, a supplier of low sugar functional hydration tablets and powders, positioning the firm to expand its presence in the active lifestyle nutrition market, a company release announced Monday. Financial details of the transaction were not revealed.
“Every day, health-conscious consumers are becoming more aware of how functional hydration products can add to their overall well-being, as well as support them during exercise by replacing the minerals that the body loses. That growing awareness is reflected in the steady growth of the category.” Greg Behar, the chief executive officer of Nestle Health Science, said in a statement. “Nuun is a leader in the fast-growing functional hydration category with its high-quality, clean, plant-based products. We look forward to combining our companies’ expertise to bring Nuun to more people around the world.”
Established in Seattle in 2004, Nuun offers a range of powders and tablets with minerals and vitamins for energy, relaxation, and other functional applications.
“Nestle Health Science and Nuun share the same philosophy: nothing is more important than health and well-being,” Nuun CEO Kevin Rutherford, said in the release. “In joining Nestle Health Science, Nuun will further its mission of ‘hydration that empowers the world to move more.’ The Nuun team has built an incredible business and now with the reach, expertise, and capabilities of Nestle, I’m confident that together we will grow even more, making people and the plant healthier.”
The companies anticipate that the transaction will close in the third quarter of this year.
About the Author(s)
You May Also Like
Institution of Chemical Engineers Announces 2024 Award WinnersMar 5, 2024|2 Min Read
USDA Recalls: February 2024Mar 1, 2024|4 Min Read
EPA Protects At-Risk Communities Near Chemical PlantsMar 1, 2024|1 Min Read
Three Chemours Top Execs Placed on LeaveMar 1, 2024|1 Min Read